About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals North America Pharmacogenomics Market Size, Trend, Analysis, and Forecast 2030

North America Pharmacogenomics Market

North America Pharmacogenomics Market Size, Share & Trends Analysis Report By Technology (PCR, Sequencing, Microarray, Gel electrophoresis, Mass Spectrometry, Other technologies), By Application (Drug discovery, Cancer, Neurology and psychiatry, Pain management, Cardiovascular disorders, Others), By End-User (Hospitals and clinics, Biopharmaceutical firms, CROs and CDMOs, Others) and By Country(US, Canada) Forecasts, 2024-2032

Report Code: SRPH3308DR
Study Period 2020-2032 CAGR 8.46%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD XX Billion
Forecast Year 2032 Forecast Year Market Size USD XX Billion
Show More
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  • North America Pharmacogenomics Market, By Technology (2020-2030)
    1. PCR
      1. Real-time PCR
      2. Regular PCR
      3. Digital PCR
    2. Sequencing
    3. Microarray
    4. Gel electrophoresis
    5. Mass Spectrometry
    6. Other technologies
  • North America Pharmacogenomics Market, By Application (2020-2030)
    1. Drug discovery
    2. Cancer
    3. Neurology and psychiatry
    4. Pain management
    5. Cardiovascular disorders
    6. Others
  • North America Pharmacogenomics Market, By End-User (2020-2030)
    1. Hospitals and clinics
    2. Biopharmaceutical firms
    3. CROs and CDMOs
    4. Others

    Related Reports

    Global Report
    The global pharmacogenomics services market size was valued at USD 5.10 billion in 2021. It is projected to reach USD 8.84 billion by 2030, growing at a CAGR of 5.65% during the forecast period (2022–2030). Factors such as increasing preva
    Buy Now
    Global Report
    The global proteomics market size was valued at USD 28.19 billion in 2022. It is estimated to reach USD 79.50 billion by 2031, growing at a CAGR of 12.21% during the forecast period (2023–2031). The surge in pharmaceutical and biotechnolog
    Buy Now

    Purchase Benefits

    • Eligible for a free updated report next year
    • Completely customizable scope
    • 30% discount on your next purchase
    • Dedicated account manager
    • Query resolution within 24 hours
    • Permission to print the report

    We are featured on :

    www.straitsresearch.com
    © Copyright . All rights Reserved.